These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18344519)

  • 1. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis.
    Kang KH; Park SY; Rho SB; Lee JH
    Cardiovasc Res; 2008 Jul; 79(1):150-60. PubMed ID: 18344519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
    Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
    Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.
    Kou B; Vatish M; Singer DR
    Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis.
    Rho SB; Dong SM; Kang S; Seo SS; Yoo CW; Lee DO; Woo JS; Park SY
    Carcinogenesis; 2008 Nov; 29(11):2106-11. PubMed ID: 18775916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing Akt phosphorylation and activating Fas by safrole oxide inhibited angiogenesis and induced vascular endothelial cell apoptosis in the presence of fibroblast growth factor-2 and serum.
    Zhao J; Miao J; Zhao B; Zhang S; Yin D
    Int J Biochem Cell Biol; 2006; 38(9):1603-13. PubMed ID: 16702019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
    Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
    Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical effects of ethoxidine, a topoisomerase I inhibitor, in the cellular processes leading to angiogenesis on endothelial cells.
    Clere N; Faure S; Helesbeux JJ; Duval O; Andriantsitohaina R
    Carcinogenesis; 2011 Mar; 32(3):286-95. PubMed ID: 21135154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes.
    Di Simone N; Di Nicuolo F; Sanguinetti M; Castellani R; D'Asta M; Caforio L; Caruso A
    J Endocrinol; 2006 Jun; 189(3):691-9. PubMed ID: 16731799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D; Okamura M; Yoshimi H; Yamori T
    Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.
    Vizán P; Sánchez-Tena S; Alcarraz-Vizán G; Soler M; Messeguer R; Pujol MD; Lee WN; Cascante M
    Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3.
    Janssen A; Hoellenriegel J; Fogarasi M; Schrewe H; Seeliger M; Tamm E; Ohlmann A; May CA; Weber BH; Stöhr H
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2812-22. PubMed ID: 18408187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.